PD-L1 controls cancer pyroptosis

被引:21
作者
Blasco, Maria Teresa [1 ]
Gomis, Roger R. [1 ,2 ,3 ,4 ]
机构
[1] Barcelona Inst Sci & Technol, Canc Sci Program, Inst Res Biomed IRB Barcelona, Barcelona, Spain
[2] CIBERONC, Madrid, Spain
[3] Univ Barcelona, Barcelona, Spain
[4] ICREA Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain
关键词
TUMOR HYPOXIA; ANGIOGENESIS;
D O I
10.1038/s41556-020-00582-w
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Programmed death ligand-1 (PD-L1) is well known for its role as an immune checkpoint regulator, but little is known about its function in other cellular processes. A study now shows that in tumour cells PD-L1 mediates pyroptosis, an inflammatory form of cell death, by activating the expression of Gasdermine C, ultimately leading to tumour necrosis.
引用
收藏
页码:1157 / 1159
页数:3
相关论文
共 14 条
[1]   B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells [J].
Azuma, Takeshi ;
Yao, Sheng ;
Zhu, Gefeng ;
Flies, Andrew S. ;
Flies, Sarah J. ;
Chen, Lieping .
BLOOD, 2008, 111 (07) :3635-3643
[2]   Exploiting tumour hypoxia in cancer treatment [J].
Brown, JM ;
William, WR .
NATURE REVIEWS CANCER, 2004, 4 (06) :437-447
[3]   Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression [J].
Chang, Chih-Hao ;
Qiu, Jing ;
O'Sullivan, David ;
Buck, Michael D. ;
Noguchi, Takuro ;
Curtis, Jonathan D. ;
Chen, Qiongyu ;
Gindin, Mariel ;
Gubin, Matthew M. ;
van der Windt, Gerritje J. W. ;
Tonc, Elena ;
Schreiber, Robert D. ;
Pearce, Edward J. ;
Pearce, Erika L. .
CELL, 2015, 162 (06) :1229-1241
[4]   Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma [J].
Edwards, JG ;
Swinson, DEB ;
Jones, JL ;
Muller, S ;
Waller, DA ;
O'Byrne, KJ .
CHEST, 2003, 124 (05) :1916-1923
[5]   Programmed Cell Death in Animal Development and Disease [J].
Fuchs, Yaron ;
Steller, Hermann .
CELL, 2011, 147 (04) :742-758
[6]   PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis [J].
Hou, Junwei ;
Zhao, Rongce ;
Xia, Weiya ;
Chang, Chiung-Wen ;
You, Yun ;
Hsu, Jung-Mao ;
Nie, Lei ;
Chen, Yeh ;
Wang, Yu-Chuan ;
Liu, Chunxiao ;
Wang, Wei-Jan ;
Wu, Yun ;
Ke, Baozhen ;
Hsu, Jennifer L. ;
Huang, Kebin ;
Ye, Zu ;
Yang, Yi ;
Xia, Xianghou ;
Li, Yintao ;
Li, Chia-Wei ;
Shao, Bin ;
Tainer, John A. ;
Hung, Mien-Chie .
NATURE CELL BIOLOGY, 2020, 22 (10) :1264-+
[7]   Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism [J].
Karagiannis, George S. ;
Pastoriza, Jessica M. ;
Wang, Yarong ;
Harney, Allison S. ;
Entenberg, David ;
Pignatelli, Jeanine ;
Sharma, Ved P. ;
Xue, Emily A. ;
Cheng, Esther ;
D'Alfonso, Timothy M. ;
Jones, Joan G. ;
Anampa, Jesus ;
Rohan, Thomas E. ;
Sparano, Joseph A. ;
Condeelis, John S. ;
Oktay, Maja H. .
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (397)
[8]   Angiogenesis and inflammation in invasive carcinoma of the breast [J].
Lee, AHS ;
Happerfield, LC ;
Bobrow, LG ;
Millis, RR .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (08) :669-673
[9]   B7-H1 confers tumor chemoresistance by regulating MAPK/ERK activation [J].
Orzechowski, Amanda ;
Dong, Haidong .
CANCER RESEARCH, 2014, 74 (19)
[10]   Dissecting the mechanisms of immune checkpoint therapy [J].
Sharma, Padmanee ;
Allison, James P. .
NATURE REVIEWS IMMUNOLOGY, 2020, 20 (02) :75-76